


The Fund aims to achieve long term capital growth.
| Name | % Net Assets |
|---|---|
| Care UK | 3.3% |
| Dechra Pharmaceuticals | 3.1% |
| RM | 3.1% |
| Ultra Electronics Holdings | 2.9% |
| Fisher (James) & Sons | 2.4% |
| Chemring Group | 2.4% |
| BPP Holdings | 2.3% |
| Synergy Health | 2.2% |
| Dignity | 2.2% |
| Protherics | 2.2% |
| Key | % Net Assets |
|---|---|
| 3.3% | |
| 3.1% | |
| 3.1% | |
| 2.9% | |
| 87.6% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 25/01/1992 |
|---|---|
| Fund Manager | Ed Robinson |
| TER | 1.59 (30-Apr-2009) |
| Minimum Investment | |
|---|---|
| Initial | 3000 |
| Additional | 1,000 |
| Savings | 100 |
| Charges | |
|---|---|
| Initial | 4.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.21 |
You are here: research